# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-014824
Filing Date
2022-08-04
Accepted
2022-08-04 16:46:08
Documents
95
Period of Report
2022-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | bbio-20220630.htm iXBRL | 10-Q | 5155518
2 | EX-10.1 | bbio-ex10_1.htm | EX-10.1 | 1205888
3 | EX-10.2 | bbio-ex10_2.htm | EX-10.2 | 1342512
4 | EX-31.1 | bbio-ex31_1.htm | EX-31.1 | 33211
5 | EX-31.2 | bbio-ex31_2.htm | EX-31.2 | 33331
6 | EX-32.1 | bbio-ex32_1.htm | EX-32.1 | 15541
7 | EX-32.2 | bbio-ex32_2.htm | EX-32.2 | 15854
| Complete submission text file | 0000950170-22-014824.txt |  | 21990591

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
8 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | bbio-20220630.xsd | EX-101.SCH | 120351
9 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | bbio-20220630_cal.xml | EX-101.CAL | 85218
10 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | bbio-20220630_lab.xml | EX-101.LAB | 855296
11 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | bbio-20220630_def.xml | EX-101.DEF | 476598
12 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | bbio-20220630_pre.xml | EX-101.PRE | 655997
89 | EXTRACTED XBRL INSTANCE DOCUMENT | bbio-20220630_htm.xml | XML | 4179415

Mailing Address 421 KIPLING STREET PALO ALTO CA 94301
Business Address 421 KIPLING STREET PALO ALTO CA 94301 (650) 391-9740
BridgeBio Pharma, Inc. (Filer) CIK: 0001743881 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38959 | Film No.: 221137382
SIC: 2834 Pharmaceutical Preparations